TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Rocio Garcia-Carbonero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.